The pathophysiology of COVID-19 includes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binding to the alveolar epithelium, activating innate immune system and adaptive immune system, resulting in a pro-inflammatory cascade, including the release of Interleukin 6 (IL-6)12. The gene discussed is IL6; the disease is COVID-19.